Simulations Plus, Inc. (NASDAQ:SLP) Given Average Rating of "Buy" by Analysts

Shares of Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) have received a consensus recommendation of "Buy" from the seven analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $49.40.

Several research analysts recently commented on the stock. Stephens assumed coverage on shares of Simulations Plus in a report on Friday, November 15th. They issued an "overweight" rating and a $39.00 price target on the stock. William Blair restated an "outperform" rating on shares of Simulations Plus in a report on Wednesday, January 8th. StockNews.com lowered shares of Simulations Plus from a "hold" rating to a "sell" rating in a report on Monday, November 4th. Finally, KeyCorp raised their price target on shares of Simulations Plus from $35.00 to $37.00 and gave the company an "overweight" rating in a report on Friday, January 24th.

Simulations Plus Stock Down 0.8 %

Shares of SLP traded down $0.23 during mid-day trading on Wednesday, hitting $28.98. The company had a trading volume of 163,707 shares, compared to its average volume of 244,116. The business's 50-day simple moving average is $31.77 and its 200-day simple moving average is $31.92. Simulations Plus has a 1-year low of $24.00 and a 1-year high of $51.22. The stock has a market cap of $582.27 million, a PE ratio of 72.45 and a beta of 0.83.

Remove Ads

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $33.91, for a total transaction of $678,200.00. Following the completion of the sale, the director now owns 3,402,584 shares of the company's stock, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 19.40% of the company's stock.

Institutional Trading of Simulations Plus

Hedge funds have recently made changes to their positions in the stock. First Horizon Advisors Inc. boosted its holdings in Simulations Plus by 82.6% in the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company's stock worth $26,000 after purchasing an additional 370 shares during the period. Jones Financial Companies Lllp boosted its holdings in Simulations Plus by 53.6% in the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock worth $34,000 after purchasing an additional 427 shares during the period. Johnson Financial Group Inc. acquired a new position in Simulations Plus in the fourth quarter worth $39,000. Quantbot Technologies LP acquired a new position in Simulations Plus in the third quarter worth $59,000. Finally, Tower Research Capital LLC TRC boosted its holdings in Simulations Plus by 42.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock worth $72,000 after purchasing an additional 764 shares during the period. Institutional investors and hedge funds own 78.08% of the company's stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.